INDOCO REMEDIES LTD. (INDOCO) financials

INDOCO REMEDIES LTD. (INDOCO) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).[1]

Market Cap: ₹2,088Cr.
Current Price: ₹227
Stock P/E: 97.0
ROE: -0.28%
ROCE: 4.33%
Book Value: ₹119
Dividend Yield: 0.09%
52W High / Low: ₹305/162

In Jun 2026, INDOCO REMEDIES LTD. (INDOCO) reported sales ₹409 Cr and net profit ₹82 Cr.

Annual TTM: sales ₹1,701 Cr, net profit ₹105 Cr.

Shareholding: Promoters 58.86% (Jun 2026), FIIs 1.27% (Jun 2026), DIIs 17.68% (Jun 2026), Public 22.04% (Jun 2026), Others 0.14% (Jun 2026).

INDOCO quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	397	373	347	394	442	401	449	409
Expenses	344	353	344	379	389	375	386	367
Operating Profit	53	20	3	15	53	26	63	42
OPM %	13%	5%	1.0%	3.8%	12%	6%	14%	10%
Other Income	4	5	6	6	6	1	14	102
Interest	15	14	16	24	22	20	23	23
Depreciation	25	25	25	25	28	27	27	28
Profit before tax	17	-13	-31	-28	10	-20	28	93
Tax %	26%	-23%	-15%	-1%	-54%	-2%	1%	12%
Net Profit	13	-10	-26	-28	15	-20	27	82
EPS in Rs	1.39	-1.11	-2.84	-3.04	1.63	-2.17	2.96	8.92
Raw PDF	—	—	—	—	—	—	—	—

INDOCO profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,106	1,240	1,540	1,667	1,791	1,518	1,686	1,701
Expenses	982	1,016	1,212	1,380	1,532	1,389	1,528	1,516
Operating Profit	124	224	328	286	259	129	158	185
OPM %	11%	18%	21%	17%	14%	8%	9%	11%
Other Income	2	3	2	1	19	19	26	123
Interest	26	22	14	25	37	57	88	88
Depreciation	71	73	79	71	88	98	107	110
Profit before tax	29	131	236	192	153	-7	-11	110
Tax %	16%	30%	35%	26%	24%	18%	-51%	—
Net Profit	24	92	155	141	117	-9	-6	105
EPS in Rs	2.63	10.03	16.77	15.34	12.65	-0.95	-0.61	11.34
Dividend Payout %	11%	15%	13%	15%	12%	-21%	-33%	—

INDOCO balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	18	18	18	18	18	18	18	18
Reserves	643	662	750	886	1,009	1,108	1,085	1,081
Borrowings	296	262	258	257	333	514	754	760
Other Liabilities	301	330	289	327	300	320	344	506
Total Liabilities	1,258	1,272	1,317	1,488	1,660	1,961	2,201	2,365
Fixed Assets	468	590	570	555	661	732	754	851
CWIP	185	51	68	122	113	114	226	85
Investments	2	2	2	2	20	59	52	160
Other Assets	603	630	676	809	866	1,055	1,169	1,269
Total Assets	1,258	1,272	1,317	1,488	1,660	1,961	2,201	2,365

INDOCO cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	132	123	82	174	179	177	107	226
Cash from Investing Activity	-104	-56	-67	-121	-209	-302	-276	-87
Cash from Financing Activity	-16	-64	-30	-44	23	122	169	-133
Net Cash Flow	12	3	-14	8	-7	-3	-0	6
Free Cash Flow	39	64	6	49	-9	-1	-148	145
CFO/OP	177%	102%	46%	66%	84%	80%	96%	147%

INDOCO shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	58.76%	58.80%	58.90%	58.90%	58.90%	58.90%	58.86%	58.86%
FIIs	1.70%	1.25%	1.24%	1.22%	1.25%	1.10%	0.94%	1.27%
DIIs	18.25%	18.91%	18.75%	18.96%	18.16%	18.15%	18.15%	17.68%
Public	21.27%	21.02%	21.02%	20.82%	21.60%	21.76%	21.90%	22.04%
Others	0.03%	0.03%	0.09%	0.09%	0.09%	0.09%	0.14%	0.14%
No. of Shareholders	34,416	34,676	34,497	33,129	33,319	32,659	32,276	32,457

INDOCO key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	73	69	69	70	77	83	90	117
Inventory Days	209	230	245	248	228	207	299	235
Days Payable	195	184	119	108	89	79	121	190
Cash Conversion Cycle	88	115	195	210	217	211	267	162
Working Capital Days	21	21	59	77	81	64	56	47
ROCE %	1%	6%	16%	23%	17%	12%	3%	4%

INDOCOUpdated 13 Oct 2026, 17:46

Indoco Remedies Ltd.

INDOCOUpdated 13 Oct 2026, 17:46

Market Cap

₹2,088Cr.

Current Price

₹227

High / Low

₹305/162

Stock P/E

97.0

ROE-0.28%

ROCE4.33%

Book Value₹119

Face Value₹2.00

Dividend Yield0.09%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	423	8	360	0	20	36	27	26	2.81
Sep 2023	473	8	401	1	21	44	25	33	3.6
Dec 2023	449	10	384	-5	23	27	26	20	2.17
Mar 2024	445	11	388	24	24	46	19	38	4.07
Jun 2024	401	12	350	4	24	20	23	15	1.62
Sep 2024	397	15	344	4	25	17	26	13	1.39
Dec 2024	373	14	353	5	25	-13	-23	-10	-1.11
Mar 2025	347	16	344	6	25	-31	-15	-26	-2.84
Jun 2025	394	24	379	6	25	-28	-1	-28	-3.04
Sep 2025	442	22	389	6	28	10	-54	15	1.63
Dec 2025	401	20	375	1	27	-20	-2	-20	-2.17
Mar 2026	449	23	386	14	27	28	1	27	2.96
Jun 2026	409	23	367	102	28	93	12	82	8.92

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	851	10	686	2	47	109	24	83	8.99
Mar 2016	1005	12	834	1	61	99	17	82	8.93
Mar 2017	1072	6	915	4	63	91	15	77	8.41
Mar 2018	1038	24	903	5	68	48	15	41	4.47
Mar 2019	968	21	891	6	72	-9	-69	-3	-0.31
Mar 2020	1106	26	982	2	71	29	16	24	2.63
Mar 2021	1240	22	1016	3	73	131	30	92	10.03
Mar 2022	1540	14	1212	2	79	236	35	155	16.77
Mar 2023	1667	25	1380	1	71	192	26	141	15.34
Mar 2024	1791	37	1532	19	88	153	24	117	12.65
Mar 2025	1518	57	1389	19	98	-7	18	-9	-0.95
Mar 2026	1686	88	1528	26	107	-11	-51	-6	-0.61
TTM	1701	88	1516	123	110	110	—	105	11.34

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	58.86%
FIIs	1.27%
DIIs	17.68%
Public	22.04%
Others	0.14%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public	Others
Sep 2023	58.75%	1.59%	17.79%	—	21.87%	0%
Dec 2023	58.75%	1.69%	19.56%	—	20%	0%
Mar 2024	58.72%	1.92%	19.41%	—	19.92%	0.03%
Jun 2024	58.76%	1.48%	18.67%	—	21.07%	0.03%
Sep 2024	58.76%	1.7%	18.25%	—	21.27%	0.03%
Dec 2024	58.8%	1.25%	18.91%	—	21.02%	0.03%
Mar 2025	58.9%	1.24%	18.75%	—	21.02%	0.09%
Jun 2025	58.9%	1.22%	18.96%	—	20.82%	0.09%
Sep 2025	58.9%	1.25%	18.16%	—	21.6%	0.09%
Dec 2025	58.9%	1.1%	18.15%	—	21.76%	0.09%
Mar 2026	58.86%	0.94%	18.15%	—	21.9%	0.14%
Jun 2026	58.86%	1.27%	17.68%	—	22.04%	0.14%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	18	500	94	229	842	339	63	1	439	842
Mar 2016	18	558	139	224	939	373	55	18	493	939
Mar 2017	18	633	280	266	1197	440	91	3	664	1197
Mar 2018	18	657	282	280	1238	489	136	3	611	1238
Mar 2019	18	643	296	301	1258	468	185	2	603	1258
Mar 2020	18	662	262	330	1272	590	51	2	630	1272
Mar 2021	18	750	258	289	1317	570	68	2	676	1317
Mar 2022	18	886	257	327	1488	555	122	2	809	1488
Mar 2023	18	1009	333	300	1660	661	113	20	866	1660
Mar 2024	18	1108	514	320	1961	732	114	59	1055	1961
Mar 2025	18	1085	754	344	2201	754	226	52	1169	2201
Mar 2026	18	1081	760	506	2365	851	85	160	1269	2365

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	110	-88	-21	1
Mar 2016	112	-113	0	0
Mar 2017	88	-171	132	50
Mar 2018	123	-135	-39	-51
Mar 2019	132	-104	-16	12
Mar 2020	123	-56	-64	3
Mar 2021	82	-67	-30	-14
Mar 2022	174	-121	-44	8
Mar 2023	179	-209	23	-7
Mar 2024	177	-302	122	-3
Mar 2025	107	-276	169	0
Mar 2026	226	-87	-133	6

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	66	68	73	73	73	69	69	70	77	83	90	117
Inventory Days	179	173	188	204	209	230	245	248	228	207	299	235
Days Payable	145	137	167	158	195	184	119	108	89	79	121	190
Cash Conversion Cycle	100	103	95	119	88	115	195	210	217	211	267	162
Working Capital Days	46	48	40	38	21	21	59	77	81	64	56	47
ROCE %	21%	17%	12%	7%	1%	6%	16%	23%	17%	12%	3%	4%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of INDOCO REMEDIES LTD. (INDOCO)?

The reported market capitalisation for INDOCO REMEDIES LTD. (INDOCO) is ₹2,088Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of INDOCO?

The current price shown for INDOCO REMEDIES LTD. (INDOCO) on Fincrux is ₹227 with a 52-week high/low of ₹305/162.

What is the P/E ratio of INDOCO REMEDIES LTD. (INDOCO)?

The stock P/E for INDOCO REMEDIES LTD. (INDOCO) is 97.0 on Fincrux, with ROE at -0.28% and ROCE at 4.33%.

What were INDOCO latest quarterly results?

For Jun 2026, INDOCO REMEDIES LTD. (INDOCO) reported sales ₹409 Cr and net profit ₹82 Cr (figures in ₹ crore unless noted).

What are INDOCO annual sales and net profit?

For TTM, INDOCO REMEDIES LTD. (INDOCO) shows sales of ₹1,701 Cr and net profit of ₹105 Cr on the Fincrux profit & loss statement.

Who owns INDOCO REMEDIES LTD. (INDOCO)?

Latest shareholding for INDOCO REMEDIES LTD. (INDOCO) on Fincrux: Promoters 58.86% (Jun 2026), FIIs 1.27% (Jun 2026), DIIs 17.68% (Jun 2026), Public 22.04% (Jun 2026), Others 0.14% (Jun 2026).

Where can I find INDOCO REMEDIES LTD. (INDOCO) financials?

INDOCO REMEDIES LTD. (INDOCO) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show INDOCO balance sheet and cash flow?

Yes. The INDOCO REMEDIES LTD. (INDOCO) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 17:46